It is interesting that only 3–4% of MDS patients are reported to have WT1 mutations, although a significant proportion of patients with MDS have TET2 mutations, and therefore are unlikely to harbor concurrent WT1 mutations if these mutations are linked in a common functional pathway. The gene discussed is TET2; the disease is myelodysplastic syndrome.